Wedmont Private Capital acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 5,726 shares of the company's stock, valued at approximately $298,000.
A number of other large investors have also recently made changes to their positions in the stock. CWA Asset Management Group LLC boosted its holdings in Doximity by 46.1% in the 4th quarter. CWA Asset Management Group LLC now owns 16,298 shares of the company's stock worth $870,000 after buying an additional 5,146 shares during the period. Nordea Investment Management AB boosted its stake in shares of Doximity by 6.2% in the fourth quarter. Nordea Investment Management AB now owns 52,176 shares of the company's stock worth $2,815,000 after acquiring an additional 3,053 shares during the period. GAMMA Investing LLC grew its position in shares of Doximity by 20.6% during the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after purchasing an additional 296 shares in the last quarter. JPMorgan Chase & Co. raised its stake in Doximity by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 498,056 shares of the company's stock valued at $21,700,000 after purchasing an additional 15,771 shares during the period. Finally, Lord Abbett & CO. LLC purchased a new position in Doximity in the 3rd quarter worth approximately $29,453,000. 87.19% of the stock is owned by hedge funds and other institutional investors.
Doximity Stock Up 1.1 %
NASDAQ:DOCS traded up $0.57 during mid-day trading on Friday, hitting $53.78. 765,975 shares of the stock traded hands, compared to its average volume of 1,391,403. The stock has a market capitalization of $10.04 billion, a price-to-earnings ratio of 61.82, a PEG ratio of 4.12 and a beta of 1.38. Doximity, Inc. has a 52 week low of $22.96 and a 52 week high of $61.75. The firm's 50 day moving average is $53.81 and its two-hundred day moving average is $42.25.
Analysts Set New Price Targets
A number of brokerages have issued reports on DOCS. Bank of America increased their price objective on shares of Doximity from $54.00 to $57.00 and gave the company a "neutral" rating in a report on Monday, January 6th. Mizuho initiated coverage on shares of Doximity in a research note on Wednesday, December 4th. They set a "neutral" rating and a $55.00 target price for the company. Stephens assumed coverage on shares of Doximity in a research note on Friday, December 20th. They issued an "equal weight" rating and a $55.00 price target on the stock. Evercore ISI increased their price objective on shares of Doximity from $34.00 to $45.00 and gave the company an "in-line" rating in a report on Tuesday, October 8th. Finally, Morgan Stanley raised Doximity from an "underweight" rating to an "equal weight" rating and lifted their target price for the stock from $33.00 to $53.00 in a report on Thursday, November 14th. Thirteen research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Doximity has an average rating of "Hold" and a consensus target price of $53.12.
Check Out Our Latest Stock Analysis on Doximity
Doximity Profile
(
Free Report)
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
Before you consider Doximity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.
While Doximity currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.